Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

Alec Kimmelman, MD, PhD, and Shridar Ganesan, MD, PhD, discuss the institution's new molecular oncology program.

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical ...

IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal ...

The study is based on the analysis of human senescent cells in a specific tumor model — melanoma, which affects skin cells known as melanocytes — and, more specifically, melanocytes exposed to ...

They block the molecular pathways that are critical ... may help with the side effects of cancer treatment but are ineffective at treating the cancer itself. Speak with your doctor about which ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...